GGrantIndex
Sort

23,748 grants matching melanoma

Engineered Ensemble Nanoimmunotherapies for Cancer

$437,707
Rohan Fernandes · George Washington University · R37 · FY2024 · CA

PATHOGENESIS OF FEVER IN HUMANS

$437,695
University Of Colorado Denver · R01 · FY2000 · AI

NanoOptogenetic immunotherapy for B cell lymphoma

$437,693
Gang Han · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · CA

Biospecimen Core/Immunologic Monitoring and Cellular Products Laboratory

$437,509
Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P50 · FY2017 · CA

Project 2:Nanoparticle-based Immune Modulators in Cancer Therapy & Vaccines

$437,489
Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U54 · FY2015 · CA

The role of transcription elongation defects in immunotherapy resistance in cancers

$437,206
Fukun Guo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · CA

The role of transcription elongation defects in immunotherapy resistance in cancers

$437,202
Fukun Guo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA

Role of MFG-E8 in Tumor Biology and Immunophysiology

$437,190
Mark Udey · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Developmental therapy for selectively targeting MEK-ERK pathway in cancer cells and tumor stromal compartment

$436,990
Shihui Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA

Murine & Human In Vivo Models of Melanoma Formation

$436,825
Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · P01 · FY2010 · ES

Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma

$436,798
Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2023 · CA

Proj 4: Triggers for the Induction of T Cell Dysfunction on T cells in Glioblastoma

$436,798
Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2022 · CA

Using dietary glutamine supplementation for melanoma prevention and targeted therapy

$436,727
Mei Kong · University Of California-Irvine · R01 · FY2021 · CA

Regulation of T cell responses through Zap70 and TCR interaction dynamics.

$436,500
Bjoern F Lillemeier · Salk Institute For Biological Studies · R01 · FY2020 · GM

Regulation of T cell responses through Zap70 and TCR interaction dynamics.

$436,500
Bjoern F Lillemeier · Salk Institute For Biological Studies · R01 · FY2018 · GM

Regulation of T cell responses through Zap70 and TCR interaction dynamics.

$436,500
Bjoern F Lillemeier · Salk Institute For Biological Studies · R01 · FY2019 · GM

Molecular ultrasound and MRI of Vascular Development. - Renewal - 1

$436,463
Daniel H Turnbull · New York University School Of Medicine · R01 · FY2016 · HL

Deciphering the tumor suppressive functions of macroH2A

$436,463
Emily Bernstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA

Molecular ultrasound and MRI of Vascular Development. - Renewal - 1

$436,463
Daniel H Turnbull · New York University School Of Medicine · R01 · FY2017 · HL

Molecular ultrasound and MRI of Vascular Development. - Renewal - 1

$436,463
Daniel H Turnbull · New York University School Of Medicine · R01 · FY2014 · HL

Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabilities in Synovial Sarcoma

$436,396
Marc Ladanyi · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA

Apigenin restores TSP-1 expression in UVB-irradiated keratinocytes

$436,213
Olga Valery Volpert · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA

Clinical Core

$436,178
Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2013 · CA

Structure-Based Design of BRAF and PI3K Inhibitors

$436,114
Ronen Marmorstein · Wistar Institute · P01 · FY2011 · CA

Eastern Cooperative Oncology Group

$436,068
Vanderbilt University · U10 · FY2004 · CA